Systematic Reviews
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Dec 15, 2021; 13(12): 2203-2215
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.2203
Minimally invasive surgical treatment of intrahepatic cholangiocarcinoma: A systematic review
Renato Patrone, Francesco Izzo, Raffaele Palaia, Vincenza Granata, Guglielmo Nasti, Alessandro Ottaiano, Gilda Pasta, Andrea Belli
Renato Patrone, PhD ICTH, University of Naples Federico II, Naples 80100, Italy
Francesco Izzo, Raffaele Palaia, Andrea Belli, Department of Abdominal Oncology, Division of Hepatobiliary Surgical Oncology, Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Naples 80131, Italy
Vincenza Granata, Division of Radiology, Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Naples 80131, Italy
Guglielmo Nasti, Alessandro Ottaiano, SSD-Innovative Therapies for Abdominal Metastases, Clinical and Experimental Abdominal Oncology, Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Naples 80131, Italy
Gilda Pasta, Division of Anesthesia, Pain medicine and Supportive Care, Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Naples 80131, Italy
Author contributions: All authors contributed significantly to the present research and reviewed the entire manuscript. Patrone R and Belli A participated substantially in the conception, design and execution of the study and in the analysis and interpretation of the data; they also participated substantially in the drafting and editing of the manuscript; Izzo F, Palaia R, Granata V, Nasti G, Ottaiano A and Pasta G participated substantially in the conception, design and execution of the study and in the review of the data.
Conflict-of-interest statement: Authors have no conflict of interest.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Andrea Belli, MD, Postdoc, Surgeon, Department of Abdominal Oncology, Division of Hepatobiliary Surgical Oncology, Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Via Mariano Semmola, Naples 80131, Italy. a.belli@istitutotumori.na.it
Received: March 23, 2021
Peer-review started: March 23, 2021
First decision: May 3, 2021
Revised: May 30, 2021
Accepted: October 31, 2021
Article in press: October 31, 2021
Published online: December 15, 2021
Processing time: 266 Days and 6 Hours
Core Tip

Core Tip: Reports on the minimally invasive treatment of intrahepatic cholanciocarcinoma are scanty and no clear evidences on the feasibility, safety and oncological results are currently available. The aim of our study is to review and summarize the current evidences on the topic and to compare the short and long term outcomes to those of open surgical resection.